0.65
+0.009(+1.41%)
Currency In USD
| Previous Close | 0.64 |
| Open | 0.64 |
| Day High | 0.65 |
| Day Low | 0.6 |
| 52-Week High | 4 |
| 52-Week Low | 0.4 |
| Volume | 474,210 |
| Average Volume | 789,180 |
| Market Cap | 10.94M |
| PE | -2.95 |
| EPS | -0.22 |
| Moving Average 50 Days | 0.69 |
| Moving Average 200 Days | 1.24 |
| Change | 0.01 |
If you invested $1000 in Kairos Pharma, Ltd. (KAPA) since IPO date, it would be worth $249.62 as of June 25, 2025 at a share price of $0.649. Whereas If you bought $1000 worth of Kairos Pharma, Ltd. (KAPA) shares 6 months ago, it would be worth $388.62 as of June 25, 2025 at a share price of $0.649.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Kapa Gold Announces the Results of Its 2025 Annual General Meeting
Newsfile
Jun 13, 2025 5:25 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - KAPA GOLD INC. (TSXV: KAPA) ("Kapa" or the "Company") is pleased to announce the results of its annual meeting of shareholders held virtually online on June 11, 2025 (the "Meeting"). The
Kairos Pharma, Ltd. Announces Participation in the D. Boral Capital Inaugural Global Conference
Newsfile
May 06, 2025 12:00 PM GMT
Los Angeles, California--(Newsfile Corp. - May 6, 2025) - Kairos Pharma, Ltd. (NYSE American: KAPA) today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.
CEO.CA's Inside the Boardroom: Kairos Pharma's Breakthrough Cancer Treatment & What's Next for ENV105
Newsfile
Mar 28, 2025 1:03 PM GMT
Toronto, Ontario--(Newsfile Corp. - March 28, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded in 2012, CEO.CA, a wholly owned subsidiary